FDA Letter API

Nutrishare Inc

Letter data

Company
Nutrishare Inc
Recipient
Rodney J. Okamoto | Owner and President | Nutrishare Inc | 9850 Kent Street | Elk Grove | , | CA | 95624 | United States
Issue date
2020-03-04
Posted date
Not available
FDA office
Division of Pharmaceutical Quality Operations III
Subject
Not available
Product
Drugs
CMS ID
543730
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Nutrishare Inc MARCS-CMS 543730 — March 04, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: UPS Next Day Product: Drugs Recipient: Recipient Name Rodney J. Okamoto Recipient Title Owner and President Nutrishare Inc 9850 Kent Street Elk Grove , CA 95624 United States Issuing Office: Division of Pharmaceutical Quality Operations III United States (313) 393-8100 Dear Mr. Okamoto: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [Case #543730, January 16, 2018]. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Nicholas F. Lyons Compliance Director Division of Pharmaceutical Quality Operations III cc: Gregory M. Killmeier Operations Manager & Pharmacist in Charge Nutrishare Inc. 11020 Plantside Drive Louisville, KY 40299-6105 Content current as of: 03/04/2020 Regulated Product(s) Drugs